Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

FDA issues nonapprovable letter for Avita; development elsewhere on track

July 5, 1996

ProCyte launches Iamin gel in U.S.

July 5, 1996

ICN's Viquin Forte launched in U.S.

June 28, 1996

Connective Therapeutics to develop new formulation of betamethasone valerate

June 28, 1996

Collagen Corporation and Biomatrix enter marketing agreement

June 21, 1996

KCB-1 skin ulcer clinical trials completed

June 21, 1996

Positive phase III results for new Solarase formulation

June 21, 1996

5alpha-reductase type 1 inhibitors from Merck & Co.

June 21, 1996

Botulinum toxin type A as dermatology remedy

June 14, 1996

Positive phase III results for Phytopharm's Zemaphyte

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...